Literature DB >> 17342368

Kidney metastasis of resected early gastric carcinoma: report of a case.

Yoshiyuki Wada1, Kazuhiro Yoshida, Jun Hihara, Kazuaki Tanabe, Kei Ukon.   

Abstract

We report a rare case of kidney metastasis of resected early gastric cancer in a 67-year-old man. We performed distal gastrectomy with D2 lymph node dissection for early gastric cancer, which was histologically diagnosed as moderately differentiated adenocarcinoma (T1N0M0, stage IA). Preoperatively, his serum carcinoembryonic antigen (CEA) level was 9.5 ng/ml, and this dropped to 7.0 ng/ml postoperatively. However, 1 year 10 months after the operation, we performed partial kidney resection and the lesion was confirmed to be a metastasis of the gastric cancer. Unfortunately, 5 months later, multiple liver metastasis was found, accompanied by a further increase in the serum CEA level to 2 650.8 ng/ml. This case illustrates the poor prognosis associated with a high preoperative serum CEA level, even if early gastric cancer is resected curatively.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17342368     DOI: 10.1007/s00595-006-3364-9

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  10 in total

1.  Quantitative detection of carcinoembryonic antigen messenger RNA in the peritoneal cavity of gastric cancer patients by real-time quantitative reverse transcription polymerase chain reaction.

Authors:  Hideaki Ueno; Kazuhiro Yoshida; Toshihiro Hirai; Fujiko Kono; Masayuki Kambe; Tetsuya Toge
Journal:  Anticancer Res       Date:  2003 Mar-Apr       Impact factor: 2.480

2.  Secondary carcinomas of the kidney.

Authors:  D G Wagle; R H Moore; G P Murphy
Journal:  J Urol       Date:  1975-07       Impact factor: 7.450

3.  2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology.

Authors:  R C Bast; P Ravdin; D F Hayes; S Bates; H Fritsche; J M Jessup; N Kemeny; G Y Locker; R G Mennel; M R Somerfield
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

4.  Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry.

Authors:  Keiichi Maruyama; Michio Kaminishi; Ken-Ichi Hayashi; Yoh Isobe; Ichiro Honda; Hitoshi Katai; Kuniyoshi Arai; Yasuhiro Kodera; Atsushi Nashimoto
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

5.  The usefulness of CEA as an indicator for early detection and a guide to the treatment of recurrent gastric cancer.

Authors:  T Kano; T Koga; K Souda; Y Abe; T Yonemura; N Oka; K Inokuchi
Journal:  Jpn J Surg       Date:  1987-07

Review 6.  The present status of DEA in diagnosis, prognosis, and evaluation of therapy.

Authors:  N Zamcheck
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

7.  The prognostic value of preoperative serum levels of CEA and CA19-9 in patients with gastric cancer.

Authors:  Y Kodera; Y Yamamura; A Torii; K Uesaka; T Hirai; K Yasui; T Morimoto; T Kato; T Kito
Journal:  Am J Gastroenterol       Date:  1996-01       Impact factor: 10.864

8.  The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study.

Authors:  Yutaka Takahashi; Tetsuo Takeuchi; Junichi Sakamoto; Tetsuya Touge; Masayoshi Mai; Hisanao Ohkura; Susumu Kodaira; Kunio Okajima; Hiroaki Nakazato
Journal:  Gastric Cancer       Date:  2003       Impact factor: 7.370

9.  Carcinoembryonic antigen levels in the peritoneal cavity: useful guide to peritoneal recurrence and prognosis for gastric cancer.

Authors:  M Nishiyama; I Takashima; T Tanaka; K Yoshida; T Toge; N Nagata; S Iwamori; Y Tamura
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352

10.  Prognostic value of preoperative serum CEA level compared to clinical staging: II. Stomach cancer.

Authors:  H J Staab; F A Anderer; T Brümmendorf; A Hornung; R Fischer
Journal:  Br J Cancer       Date:  1982-05       Impact factor: 7.640

  10 in total
  1 in total

1.  Mitochondria in tumour progression: a network of mtDNA variants in different types of cancer.

Authors:  Giovanna C Cavalcante; Ândrea Ribeiro-Dos-Santos; Gilderlanio S de Araújo
Journal:  BMC Genom Data       Date:  2022-02-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.